Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 8, p. 749, doi. 10.1093/jjco/hyv064
- By:
- Publication type:
- Article
Works by Gundeti, Sadasivudu
Results: 4
1
2
Impact of Polymorphisms of TP53 Arg72Pro, Excision Repair Cross-complementing Protein 1 Asn118Asn (C118T) and Deletion in Intron 2 of BIM in Chronic Myeloid Leukemia Patients on Imatinib Treatment.
- Published in:
- Journal of Natural Science, Biology & Medicine, 2018, v. 9, n. 2, p. 185, doi. 10.4103/jnsbm.JNSBM_194_17
- By:
- Publication type:
- Article
3
Assessment of BCR-ABL1 Fusion Transcripts and Their Association with Response to Imatinib Treatment in Chronic Myeloid Leukemia Patients.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2018, v. 39, n. 2, p. 165, doi. 10.4103/ijmpo.ijmpo_80_17
- By:
- Publication type:
- Article
4
AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01700-x
- By:
- Publication type:
- Article